Drugs / Insulin lispro low mixture
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00548808 | Nov 2007 → Aug 2009 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin lispro low mixture | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00548808 ↗ |
| Known as | LM25 | “25% insulin lispro, 75% insulin lispro protamine suspension (LM25)” PMID 22672081 ↗ Sep 2012 |
| Route | Subcutaneous | “subcutaneous injection before meal” NCT00548808 ↗ |